PMC:7205724 / 21921-22331 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"760","span":{"begin":374,"end":382},"obj":"Species"},{"id":"761","span":{"begin":58,"end":63},"obj":"Species"},{"id":"762","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"763","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"764","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"765","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"766","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"767","span":{"begin":287,"end":327},"obj":"Disease"}],"attributes":[{"id":"A760","pred":"tao:has_database_id","subj":"760","obj":"Tax:9606"},{"id":"A761","pred":"tao:has_database_id","subj":"761","obj":"Tax:9606"},{"id":"A762","pred":"tao:has_database_id","subj":"762","obj":"MESH:C502936"},{"id":"A763","pred":"tao:has_database_id","subj":"763","obj":"MESH:D001327"},{"id":"A764","pred":"tao:has_database_id","subj":"764","obj":"MESH:D001172"},{"id":"A765","pred":"tao:has_database_id","subj":"765","obj":"MESH:D013700"},{"id":"A766","pred":"tao:has_database_id","subj":"766","obj":"MESH:D001171"},{"id":"A767","pred":"tao:has_database_id","subj":"767","obj":"MESH:D001171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T160","span":{"begin":77,"end":85},"obj":"Body_part"},{"id":"T161","span":{"begin":167,"end":175},"obj":"Body_part"},{"id":"T162","span":{"begin":222,"end":226},"obj":"Body_part"}],"attributes":[{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T165","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"T166","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"T167","span":{"begin":205,"end":214},"obj":"Disease"},{"id":"T168","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"T169","span":{"begin":227,"end":236},"obj":"Disease"},{"id":"T170","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"T171","span":{"begin":252,"end":281},"obj":"Disease"},{"id":"T172","span":{"begin":272,"end":281},"obj":"Disease"},{"id":"T173","span":{"begin":298,"end":327},"obj":"Disease"},{"id":"T174","span":{"begin":318,"end":327},"obj":"Disease"}],"attributes":[{"id":"A165","pred":"mondo_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A166","pred":"mondo_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A167","pred":"mondo_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"},{"id":"A168","pred":"mondo_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/MONDO_0008538"},{"id":"A169","pred":"mondo_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/MONDO_0043494"},{"id":"A170","pred":"mondo_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/MONDO_0018456"},{"id":"A171","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0011429"},{"id":"A172","pred":"mondo_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"},{"id":"A173","pred":"mondo_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/MONDO_0011429"},{"id":"A174","pred":"mondo_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T261","span":{"begin":41,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T262","span":{"begin":43,"end":52},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T263","span":{"begin":58,"end":63},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T264","span":{"begin":222,"end":226},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T100","span":{"begin":142,"end":150},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T101","span":{"begin":222,"end":226},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T216","span":{"begin":58,"end":63},"obj":"Species"}],"attributes":[{"id":"A216","pred":"ncbi_taxonomy_id","subj":"T216","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T179","span":{"begin":0,"end":328},"obj":"Sentence"},{"id":"T180","span":{"begin":329,"end":410},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"762","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"761","span":{"begin":58,"end":63},"obj":"Species"},{"id":"763","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"764","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"765","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"766","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"767","span":{"begin":287,"end":327},"obj":"Disease"},{"id":"760","span":{"begin":374,"end":382},"obj":"Species"}],"attributes":[{"id":"A766","pred":"pubann:denotes","subj":"766","obj":"MESH:D001171"},{"id":"A767","pred":"pubann:denotes","subj":"767","obj":"MESH:D001171"},{"id":"A761","pred":"pubann:denotes","subj":"761","obj":"Tax:9606"},{"id":"A764","pred":"pubann:denotes","subj":"764","obj":"MESH:D001172"},{"id":"A765","pred":"pubann:denotes","subj":"765","obj":"MESH:D013700"},{"id":"A760","pred":"pubann:denotes","subj":"760","obj":"Tax:9606"},{"id":"A763","pred":"pubann:denotes","subj":"763","obj":"MESH:D001327"},{"id":"A762","pred":"pubann:denotes","subj":"762","obj":"MESH:C502936"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-UniProt

    {"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2117","span":{"begin":64,"end":67},"obj":"Protein"}],"attributes":[{"id":"A2117","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A2118","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A2119","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A2120","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A2121","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A2122","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A2123","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A2124","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A2125","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A2126","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A2127","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A2128","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A2129","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A2130","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A2131","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A2132","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A2133","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A2134","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A2135","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A2136","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A2137","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A2138","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A2139","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A2140","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A2141","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A2142","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A2143","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A2144","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A2145","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A2146","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A2147","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A2148","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A2149","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A2150","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A2151","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A2152","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A2153","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A2154","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A2155","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A2156","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A2157","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A2158","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A2159","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A2160","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T86439","span":{"begin":0,"end":11},"obj":"NNP"},{"id":"T21494","span":{"begin":11,"end":12},"obj":"-COMMA-"},{"id":"T50157","span":{"begin":13,"end":17},"obj":"RB"},{"id":"T26283","span":{"begin":18,"end":23},"obj":"VBN"},{"id":"T43571","span":{"begin":24,"end":26},"obj":"IN"},{"id":"T44785","span":{"begin":27,"end":36},"obj":"NN"},{"id":"T96810","span":{"begin":36,"end":37},"obj":"-COMMA-"},{"id":"T58761","span":{"begin":38,"end":40},"obj":"VBZ"},{"id":"T56416","span":{"begin":41,"end":42},"obj":"DT"},{"id":"T79548","span":{"begin":43,"end":52},"obj":"JJ"},{"id":"T29074","span":{"begin":53,"end":63},"obj":"JJ"},{"id":"T88685","span":{"begin":64,"end":67},"obj":"NN"},{"id":"T26777","span":{"begin":68,"end":76},"obj":"NN"},{"id":"T24185","span":{"begin":77,"end":85},"obj":"NN"},{"id":"T17221","span":{"begin":86,"end":94},"obj":"VBN"},{"id":"T32471","span":{"begin":95,"end":97},"obj":"IN"},{"id":"T53882","span":{"begin":98,"end":101},"obj":"NNP"},{"id":"T24580","span":{"begin":102,"end":105},"obj":"IN"},{"id":"T33924","span":{"begin":106,"end":113},"obj":"JJ"},{"id":"T90119","span":{"begin":114,"end":126},"obj":"JJ"},{"id":"T59846","span":{"begin":127,"end":130},"obj":"CC"},{"id":"T31666","span":{"begin":131,"end":141},"obj":"JJ"},{"id":"T46803","span":{"begin":142,"end":150},"obj":"NNS"},{"id":"T80969","span":{"begin":151,"end":157},"obj":"JJ"},{"id":"T13017","span":{"begin":157,"end":158},"obj":"-COMMA-"},{"id":"T79015","span":{"begin":159,"end":163},"obj":"JJ"},{"id":"T43255","span":{"begin":164,"end":166},"obj":"IN"},{"id":"T47553","span":{"begin":167,"end":175},"obj":"NN"},{"id":"T34694","span":{"begin":176,"end":183},"obj":"NN"},{"id":"T36705","span":{"begin":184,"end":192},"obj":"NN"},{"id":"T68837","span":{"begin":192,"end":193},"obj":"-COMMA-"},{"id":"T30269","span":{"begin":194,"end":204},"obj":"JJ"},{"id":"T54700","span":{"begin":205,"end":214},"obj":"NN"},{"id":"T81658","span":{"begin":214,"end":215},"obj":"-COMMA-"},{"id":"T84650","span":{"begin":216,"end":221},"obj":"JJ"},{"id":"T11095","span":{"begin":222,"end":226},"obj":"NN"},{"id":"T15987","span":{"begin":227,"end":236},"obj":"NN"},{"id":"T88887","span":{"begin":236,"end":237},"obj":"-COMMA-"},{"id":"T31599","span":{"begin":238,"end":251},"obj":"JJ"},{"id":"T93322","span":{"begin":252,"end":260},"obj":"JJ"},{"id":"T49595","span":{"begin":261,"end":271},"obj":"JJ"},{"id":"T62141","span":{"begin":272,"end":281},"obj":"NN"},{"id":"T76737","span":{"begin":281,"end":282},"obj":"-COMMA-"},{"id":"T30470","span":{"begin":283,"end":286},"obj":"CC"},{"id":"T13999","span":{"begin":287,"end":297},"obj":"JJ"},{"id":"T88238","span":{"begin":298,"end":306},"obj":"JJ"},{"id":"T89892","span":{"begin":307,"end":317},"obj":"JJ"},{"id":"T97598","span":{"begin":318,"end":327},"obj":"NN"},{"id":"T25454","span":{"begin":329,"end":331},"obj":"PRP"},{"id":"T28665","span":{"begin":332,"end":334},"obj":"VBZ"},{"id":"T15312","span":{"begin":335,"end":339},"obj":"JJ"},{"id":"T18121","span":{"begin":340,"end":343},"obj":"CC"},{"id":"T2467","span":{"begin":344,"end":353},"obj":"JJ"},{"id":"T39207","span":{"begin":354,"end":357},"obj":"IN"},{"id":"T89869","span":{"begin":358,"end":362},"obj":"DT"},{"id":"T32842","span":{"begin":363,"end":369},"obj":"NNS"},{"id":"T38357","span":{"begin":370,"end":373},"obj":"CC"},{"id":"T13891","span":{"begin":374,"end":382},"obj":"NNS"},{"id":"T61388","span":{"begin":383,"end":386},"obj":"CD"},{"id":"T66576","span":{"begin":387,"end":392},"obj":"NNS"},{"id":"T46590","span":{"begin":393,"end":395},"obj":"IN"},{"id":"T15404","span":{"begin":396,"end":399},"obj":"NN"},{"id":"T19164","span":{"begin":400,"end":403},"obj":"CC"},{"id":"T99851","span":{"begin":404,"end":409},"obj":"JJR"}],"relations":[{"id":"R83125","pred":"arg1Of","subj":"T86439","obj":"T21494"},{"id":"R13146","pred":"arg1Of","subj":"T26283","obj":"T50157"},{"id":"R82868","pred":"arg2Of","subj":"T86439","obj":"T26283"},{"id":"R76811","pred":"arg1Of","subj":"T26283","obj":"T43571"},{"id":"R6462","pred":"arg2Of","subj":"T44785","obj":"T43571"},{"id":"R65301","pred":"arg1Of","subj":"T58761","obj":"T96810"},{"id":"R91756","pred":"arg1Of","subj":"T86439","obj":"T58761"},{"id":"R48338","pred":"arg2Of","subj":"T24185","obj":"T58761"},{"id":"R19276","pred":"arg1Of","subj":"T24185","obj":"T56416"},{"id":"R24087","pred":"arg1Of","subj":"T24185","obj":"T79548"},{"id":"R65895","pred":"arg1Of","subj":"T24185","obj":"T29074"},{"id":"R2263","pred":"arg1Of","subj":"T24185","obj":"T88685"},{"id":"R21524","pred":"arg1Of","subj":"T24185","obj":"T26777"},{"id":"R18021","pred":"arg1Of","subj":"T53882","obj":"T17221"},{"id":"R77534","pred":"arg2Of","subj":"T24185","obj":"T17221"},{"id":"R58214","pred":"arg2Of","subj":"T53882","obj":"T32471"},{"id":"R27887","pred":"arg1Of","subj":"T17221","obj":"T24580"},{"id":"R20734","pred":"arg2Of","subj":"T80969","obj":"T24580"},{"id":"R13465","pred":"arg1Of","subj":"T46803","obj":"T33924"},{"id":"R86212","pred":"arg1Of","subj":"T46803","obj":"T90119"},{"id":"R60939","pred":"arg1Of","subj":"T90119","obj":"T59846"},{"id":"R4444","pred":"arg2Of","subj":"T31666","obj":"T59846"},{"id":"R87485","pred":"arg1Of","subj":"T46803","obj":"T31666"},{"id":"R90538","pred":"arg1Of","subj":"T46803","obj":"T80969"},{"id":"R97819","pred":"arg1Of","subj":"T17221","obj":"T13017"},{"id":"R24341","pred":"arg1Of","subj":"T43255","obj":"T79015"},{"id":"R92610","pred":"arg1Of","subj":"T24185","obj":"T43255"},{"id":"R33248","pred":"arg2Of","subj":"T30470","obj":"T43255"},{"id":"R45357","pred":"arg1Of","subj":"T36705","obj":"T47553"},{"id":"R21959","pred":"arg1Of","subj":"T36705","obj":"T34694"},{"id":"R41949","pred":"arg1Of","subj":"T36705","obj":"T68837"},{"id":"R19260","pred":"arg2Of","subj":"T54700","obj":"T68837"},{"id":"R59437","pred":"arg1Of","subj":"T54700","obj":"T30269"},{"id":"R79844","pred":"arg1Of","subj":"T68837","obj":"T81658"},{"id":"R96846","pred":"arg2Of","subj":"T15987","obj":"T81658"},{"id":"R42046","pred":"arg1Of","subj":"T15987","obj":"T84650"},{"id":"R12475","pred":"arg1Of","subj":"T15987","obj":"T11095"},{"id":"R20864","pred":"arg1Of","subj":"T81658","obj":"T88887"},{"id":"R12170","pred":"arg2Of","subj":"T62141","obj":"T88887"},{"id":"R2759","pred":"arg1Of","subj":"T62141","obj":"T31599"},{"id":"R56313","pred":"arg1Of","subj":"T62141","obj":"T93322"},{"id":"R57671","pred":"arg1Of","subj":"T62141","obj":"T49595"},{"id":"R19638","pred":"arg1Of","subj":"T30470","obj":"T76737"},{"id":"R50655","pred":"arg1Of","subj":"T88887","obj":"T30470"},{"id":"R47508","pred":"arg2Of","subj":"T97598","obj":"T30470"},{"id":"R2665","pred":"arg1Of","subj":"T97598","obj":"T13999"},{"id":"R42821","pred":"arg1Of","subj":"T97598","obj":"T88238"},{"id":"R23852","pred":"arg1Of","subj":"T97598","obj":"T89892"},{"id":"R65763","pred":"arg1Of","subj":"T25454","obj":"T28665"},{"id":"R63345","pred":"arg2Of","subj":"T18121","obj":"T28665"},{"id":"R33385","pred":"arg1Of","subj":"T25454","obj":"T15312"},{"id":"R71645","pred":"arg1Of","subj":"T15312","obj":"T18121"},{"id":"R79824","pred":"arg2Of","subj":"T2467","obj":"T18121"},{"id":"R87665","pred":"arg1Of","subj":"T25454","obj":"T2467"},{"id":"R86934","pred":"arg1Of","subj":"T18121","obj":"T39207"},{"id":"R81304","pred":"arg2Of","subj":"T38357","obj":"T39207"},{"id":"R77360","pred":"arg1Of","subj":"T38357","obj":"T89869"},{"id":"R78333","pred":"arg1Of","subj":"T32842","obj":"T38357"},{"id":"R34196","pred":"arg2Of","subj":"T13891","obj":"T38357"},{"id":"R37501","pred":"arg1Of","subj":"T66576","obj":"T61388"},{"id":"R85448","pred":"arg1Of","subj":"T38357","obj":"T66576"},{"id":"R80686","pred":"arg1Of","subj":"T66576","obj":"T46590"},{"id":"R92175","pred":"arg2Of","subj":"T15404","obj":"T46590"},{"id":"R77190","pred":"arg1Of","subj":"T66576","obj":"T19164"},{"id":"R33791","pred":"arg2Of","subj":"T99851","obj":"T19164"},{"id":"R24950","pred":"arg1Of","subj":"T38357","obj":"T99851"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T160","span":{"begin":77,"end":85},"obj":"Body_part"},{"id":"T161","span":{"begin":167,"end":175},"obj":"Body_part"},{"id":"T162","span":{"begin":222,"end":226},"obj":"Body_part"}],"attributes":[{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T160","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"T161","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"T162","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"T163","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"T164","span":{"begin":298,"end":327},"obj":"Disease"}],"attributes":[{"id":"A162","pred":"mondo_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/MONDO_0008538"},{"id":"A164","pred":"mondo_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/MONDO_0011429"},{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A163","pred":"mondo_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/MONDO_0018456"},{"id":"A161","pred":"mondo_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sample-PD-HP

    {"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T9","span":{"begin":131,"end":150},"obj":"Phenotype"},{"id":"T10","span":{"begin":194,"end":214},"obj":"Phenotype"},{"id":"T11","span":{"begin":227,"end":236},"obj":"Phenotype"},{"id":"T12","span":{"begin":252,"end":281},"obj":"Phenotype"},{"id":"T13","span":{"begin":298,"end":327},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0005681"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0012089"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0005681"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T179","span":{"begin":0,"end":328},"obj":"Sentence"},{"id":"T180","span":{"begin":329,"end":410},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":131,"end":150},"obj":"Phenotype"},{"id":"T10","span":{"begin":167,"end":192},"obj":"Phenotype"},{"id":"T11","span":{"begin":194,"end":214},"obj":"Phenotype"},{"id":"T12","span":{"begin":227,"end":236},"obj":"Phenotype"},{"id":"T13","span":{"begin":252,"end":281},"obj":"Phenotype"},{"id":"T14","span":{"begin":298,"end":327},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0012089"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0005681"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0005681"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis. It is safe and effective for both adults and children two years of age and older."}